Riskpilot← Back to searchSign inGet full accessDeLiver Pharma ApS
APSActiveCVR 39432714Fuglevej 21Manufacture of pharmaceutical preparations · NACE 2120Est. 2018— employees
Revenue 2024
DKK -10K
-109% vs 2023
EBITDA margin
100.0%
-109% vs 2023
Equity ratio
94.7%
Financial strength
Net profit 2024
DKK -22K
-120% vs 2023
| Revenue | DKK -10K | -109% |
| EBITDA | DKK -10K | -109% |
| Net profit | DKK -22K | -120% |
| Total assets | DKK 206K | -24% |
| Equity | DKK 195K | -10% |
| Employees | — | — |
Legal name
DeLiver Pharma ApS
CVR number
39432714
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
9. marts 2018
Share capital
DKK 260.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør og bestyrelsesformanden i forening eller af den samlede bestyrelse i forening.
Company purpose
Selskabets formål er at drive virksomhed med medicinsk udvikling samt enhver i forbindelse hermed stående virksomhed.
Address
Fuglevej 21
Phone
+4521733311
Email
jonasgraversen@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | -28 | 79 | -20 | -22 | -18 | 119 | -10 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -28 | 51 | -20 | -22 | -18 | 119 | -10 |
| Depreciation & amort. | -0 | -63 | -94 | -125 | -11 | -11 | -11 |
| EBIT | -28 | -12 | -114 | -147 | -29 | 107 | -22 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -28 | -12 | -114 | -147 | -29 | 107 | -22 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -28 | -12 | -114 | -147 | -29 | 107 | -22 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 434 | 230 | 255 | 150 | 121 | 271 | 206 |
| Equity | 232 | 220 | 246 | 139 | 109 | 217 | 195 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 203 | 11 | 9 | 11 | 11 | 55 | 11 |
| Total debt | 203 | 11 | 9 | 11 | 11 | 55 | 11 |
EBITDA margin
-1030200.0%
This company
15.8%
Market median
-6520353% vs market
20182024
Equity ratio
94.7%
This company
38.2%
Market median
+148% vs market
20182024
Return on equity
-11.1%
This company
18.4%
Market median
-160% vs market
20182024
Net profit margin
-2168200.0%
This company
8.1%
Market median
-26768001% vs market
20182024
Asset turnover
-0.05×
This company
1.12×
Market median
-104% vs market
20182024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20182024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-03-09 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NJ Management | Management | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2018 | — | — | |
| Chairman | 2018 | — | — | |
| Board of Directors | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
MOESTRUP HOLDING 2007 ApS | Company | 25.0% | 25.0% | 2018 |
PHIDEAS ApS | Company | 25.0% | 25.0% | 2018 |
SCIENCE VENTURES DENMARK A/S | Company | 25.0% | 25.0% | 2018 |
MØLLER HOLDING 2007 ApS | Company | 25.0% | 25.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Syddansk Universitet (University of Southern Denmark)SCIENCE VENTURES DENMARK A/S
DeLiver Pharma ApS (this company)Board members of DeLiver Pharma ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Niels Jonas Heilskov Graversen | Management | 0 companies |
| Søren Kragh Moestrup | Board of Directors | 0 companies |
| Jens Kristian Damsgaard | Chairman | 0 companies |
| Holger Jon Møller | Board of Directors | 0 companies |